Premium
Barriers and Adherence to Pain Management in Advanced Cancer Patients
Author(s) -
Mercadante Sebastiano,
Adile Claudio,
Tirelli Walter,
Ferrera Patrizia,
Penco Italo,
Casuccio Alessandra
Publication year - 2021
Publication title -
pain practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 58
eISSN - 1533-2500
pISSN - 1530-7085
DOI - 10.1111/papr.12965
Subject(s) - medicine , depression (economics) , hospital anxiety and depression scale , brief pain inventory , cancer pain , analgesic , delirium , rating scale , anxiety , physical therapy , cancer , chronic pain , psychiatry , psychology , developmental psychology , economics , macroeconomics
Aim To assess patients’ barriers to pain management and analgesic medication adherence in patients with advanced cancer. Methods This was a prospective cross‐sectional study in patients with advanced cancer receiving chronic opioid therapy. Age, gender, cancer diagnosis, Karnofsky level, and educational status were recorded. The Brief Pain Inventory (BPI), Edmonton Symptom Assessment Scale (ESAS), Memorial Delirium Assessment Scale (MDAS), Barriers Questionnaire II (BQ‐II), Medication Adherence Rating Scale (MARS), and Hospital Anxiety and Depression Scale (HADS) were the measurement instruments used. Results One‐hundred‐thirteen patients were analyzed. The mean age was 68 (±13) years, and 59 (52%) were male. The mean Karnofsky status was 51.4 (standard deviation [SD] 11.5). The mean score for BQ‐II items was 1.77 (SD 0.7). The BQ‐II score was independently related to the HADS‐Depression score ( P = 0.033) and the total HADS score ( P = 0.049). Negative side‐effects and attitudes toward psychotropic medication globally prevailed among MARS items. These items were independently associated with gender ( P = 0.030), pain ( P = 0.003), and depression ( P = 0.047). Conclusion Barriers to pain management were mild. Psychological factors such as depression were the main factor associated with barriers. Poor adherence to analgesic medication was mostly manifested as negative side‐effects and attitudes toward psychotropic medication, was more frequent observed in females, and was associated with the ESAS items pain and depression.